Healthcare -
Biotechnology - NASDAQ - US
$ 12.92
2.8 %
$ 985 M
Market Cap
-4.48
P/E
NRIX - STOCK-BASED COMPENSATION
Stock-based Compensation NRIX - Nurix Therapeutics, Inc.
33.9 M
LAST VALUE
9.82%
2 YEAR CAGR
131.53%
5 YEAR CAGR
0.00%
10 YEAR CAGR